nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyamemazine—HTR2A—arteriole—atherosclerosis	0.115	0.296	CbGeAlD
Cyamemazine—HTR2A—vein—atherosclerosis	0.0684	0.176	CbGeAlD
Cyamemazine—HTR2A—hindlimb—atherosclerosis	0.0455	0.117	CbGeAlD
Cyamemazine—HTR2A—appendage—atherosclerosis	0.039	0.101	CbGeAlD
Cyamemazine—HTR2A—artery—atherosclerosis	0.0279	0.0719	CbGeAlD
Cyamemazine—HTR2A—endothelium—atherosclerosis	0.0235	0.0607	CbGeAlD
Cyamemazine—HTR2A—blood vessel—atherosclerosis	0.0217	0.056	CbGeAlD
Cyamemazine—CHRM2—cardiovascular system—atherosclerosis	0.02	0.0517	CbGeAlD
Cyamemazine—Isothipendyl—HRH1—atherosclerosis	0.0161	0.128	CrCbGaD
Cyamemazine—Aceprometazine—HRH1—atherosclerosis	0.0139	0.111	CrCbGaD
Cyamemazine—Methdilazine—HRH1—atherosclerosis	0.0129	0.102	CrCbGaD
Cyamemazine—HTR2A—connective tissue—atherosclerosis	0.0111	0.0287	CbGeAlD
Cyamemazine—HTR2A—cardiovascular system—atherosclerosis	0.00969	0.025	CbGeAlD
Cyamemazine—Alimemazine—HRH1—atherosclerosis	0.00942	0.0747	CrCbGaD
Cyamemazine—Mequitazine—HRH1—atherosclerosis	0.00811	0.0643	CrCbGaD
Cyamemazine—HTR2A—liver—atherosclerosis	0.00599	0.0155	CbGeAlD
Cyamemazine—Mesoridazine—HRH1—atherosclerosis	0.00569	0.0451	CrCbGaD
Cyamemazine—Prochlorperazine—HRH1—atherosclerosis	0.00551	0.0437	CrCbGaD
Cyamemazine—Fluphenazine—HRH1—atherosclerosis	0.00498	0.0395	CrCbGaD
Cyamemazine—Propiomazine—HRH1—atherosclerosis	0.00479	0.038	CrCbGaD
Cyamemazine—Chlorprothixene—HRH1—atherosclerosis	0.00454	0.036	CrCbGaD
Cyamemazine—Thioridazine—HRH1—atherosclerosis	0.00429	0.034	CrCbGaD
Cyamemazine—Trimipramine—HRH1—atherosclerosis	0.00419	0.0332	CrCbGaD
Cyamemazine—Methotrimeprazine—HRH1—atherosclerosis	0.0041	0.0325	CrCbGaD
Cyamemazine—Promethazine—HRH1—atherosclerosis	0.00404	0.032	CrCbGaD
Cyamemazine—Trifluoperazine—HRH1—atherosclerosis	0.00398	0.0316	CrCbGaD
Cyamemazine—Perphenazine—HRH1—atherosclerosis	0.00394	0.0312	CrCbGaD
Cyamemazine—Promazine—HRH1—atherosclerosis	0.00355	0.0282	CrCbGaD
Cyamemazine—Chlorpromazine—HRH1—atherosclerosis	0.00313	0.0248	CrCbGaD
Cyamemazine—Imipramine—HRH1—atherosclerosis	0.00311	0.0247	CrCbGaD
Cyamemazine—Acepromazine—ALB—atherosclerosis	0.00138	0.011	CrCbGaD
Cyamemazine—Thioproperazine—ALB—atherosclerosis	0.00135	0.0107	CrCbGaD
Cyamemazine—Pipotiazine—ALB—atherosclerosis	0.00133	0.0106	CrCbGaD
Cyamemazine—Clomipramine—ALB—atherosclerosis	0.00105	0.00834	CrCbGaD
Cyamemazine—Chlorpromazine—ALB—atherosclerosis	0.000722	0.00572	CrCbGaD
Cyamemazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.00047	0.000966	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—APOA2—atherosclerosis	0.000467	0.000961	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—APOA4—atherosclerosis	0.000463	0.000952	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CCR2—atherosclerosis	0.000454	0.000934	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—EDNRA—atherosclerosis	0.000454	0.000934	CbGpPWpGaD
Cyamemazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000453	0.000931	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—KNG1—atherosclerosis	0.000447	0.00092	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CCR2—atherosclerosis	0.000446	0.000917	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—EDNRA—atherosclerosis	0.000446	0.000917	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—UTS2—atherosclerosis	0.000446	0.000917	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—AGTR1—atherosclerosis	0.000445	0.000915	CbGpPWpGaD
Cyamemazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000445	0.000914	CbGpPWpGaD
Cyamemazine—HTR2A—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000444	0.000913	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—GHRL—atherosclerosis	0.000443	0.00091	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—CCL2—atherosclerosis	0.000436	0.000897	CbGpPWpGaD
Cyamemazine—CHRM2—SIDS Susceptibility Pathways—IL6—atherosclerosis	0.000436	0.000897	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—GHRL—atherosclerosis	0.000435	0.000894	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CCL4—atherosclerosis	0.000434	0.000893	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—CCL2—atherosclerosis	0.000428	0.000881	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—KNG1—atherosclerosis	0.000428	0.00088	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CX3CR1—atherosclerosis	0.000427	0.000879	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CASR—atherosclerosis	0.000427	0.000879	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CCL4—atherosclerosis	0.000426	0.000877	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—AGTR1—atherosclerosis	0.000425	0.000875	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—KNG1—atherosclerosis	0.00042	0.000864	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CX3CL1—atherosclerosis	0.000419	0.000862	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—AGTR1—atherosclerosis	0.000418	0.000859	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—EDN1—atherosclerosis	0.000415	0.000854	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—CCL5—atherosclerosis	0.000412	0.000847	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—APOA2—atherosclerosis	0.000406	0.000835	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—APOA2—atherosclerosis	0.000398	0.000819	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CNR2—atherosclerosis	0.000397	0.000817	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR ligand binding—CXCL8—atherosclerosis	0.000397	0.000817	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—MMP3—atherosclerosis	0.000396	0.000815	CbGpPWpGaD
Cyamemazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000396	0.000814	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—PRKCG—atherosclerosis	0.000392	0.000806	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—KNG1—atherosclerosis	0.000388	0.000799	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—UTS2—atherosclerosis	0.000387	0.000796	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—AGTR1—atherosclerosis	0.000386	0.000794	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—KNG1—atherosclerosis	0.000381	0.000785	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—UTS2—atherosclerosis	0.00038	0.000782	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—AGTR1—atherosclerosis	0.000379	0.00078	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—EDN1—atherosclerosis	0.000377	0.000775	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CCL5—atherosclerosis	0.000374	0.000769	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CX3CR1—atherosclerosis	0.000371	0.000763	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CASR—atherosclerosis	0.000371	0.000763	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CX3CR1—atherosclerosis	0.000364	0.000749	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CASR—atherosclerosis	0.000364	0.000749	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CX3CL1—atherosclerosis	0.000364	0.000749	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—EDN1—atherosclerosis	0.00036	0.000742	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CCL5—atherosclerosis	0.000358	0.000736	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CX3CL1—atherosclerosis	0.000357	0.000735	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—PRKCG—atherosclerosis	0.000356	0.000732	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—VWF—atherosclerosis	0.000354	0.000728	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—EDN1—atherosclerosis	0.000354	0.000728	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—APOC3—atherosclerosis	0.000352	0.000724	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CCL5—atherosclerosis	0.000351	0.000722	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—LDLR—atherosclerosis	0.00035	0.000719	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CNR2—atherosclerosis	0.000345	0.00071	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR ligand binding—CXCL8—atherosclerosis	0.000345	0.000709	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—AGT—atherosclerosis	0.000345	0.000709	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—MMP3—atherosclerosis	0.000344	0.000708	CbGpPWpGaD
Cyamemazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000343	0.000706	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CCL3—atherosclerosis	0.000342	0.000703	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—PRKCG—atherosclerosis	0.00034	0.0007	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CNR2—atherosclerosis	0.000339	0.000697	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR ligand binding—CXCL8—atherosclerosis	0.000339	0.000696	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—MMP3—atherosclerosis	0.000338	0.000695	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—PRKCG—atherosclerosis	0.000334	0.000687	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—EDN1—atherosclerosis	0.000327	0.000673	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NCF1—atherosclerosis	0.000327	0.000673	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CCL5—atherosclerosis	0.000325	0.000668	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—EDN1—atherosclerosis	0.000321	0.000661	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CCL5—atherosclerosis	0.000319	0.000656	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—F2—atherosclerosis	0.000318	0.000655	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—AGT—atherosclerosis	0.000313	0.000644	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—EDNRA—atherosclerosis	0.000309	0.000636	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CCR2—atherosclerosis	0.000309	0.000636	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—PRKCG—atherosclerosis	0.000309	0.000635	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CYBA—atherosclerosis	0.000308	0.000633	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—VWF—atherosclerosis	0.000307	0.000632	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—APOC3—atherosclerosis	0.000306	0.000629	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000305	0.000627	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—LDLR—atherosclerosis	0.000304	0.000625	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—PRKCG—atherosclerosis	0.000303	0.000624	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—VWF—atherosclerosis	0.000302	0.000621	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PLAT—atherosclerosis	0.000301	0.000619	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PARP1—atherosclerosis	0.000301	0.000619	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—GHRL—atherosclerosis	0.000301	0.000619	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—APOC3—atherosclerosis	0.0003	0.000617	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—AGT—atherosclerosis	0.000299	0.000616	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—LDLR—atherosclerosis	0.000298	0.000613	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CCL3—atherosclerosis	0.000297	0.00061	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—AGT—atherosclerosis	0.000294	0.000604	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CCL3—atherosclerosis	0.000291	0.000599	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—F2—atherosclerosis	0.000289	0.000595	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NCF1—atherosclerosis	0.000284	0.000584	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NCF1—atherosclerosis	0.000279	0.000574	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—PIK3CG—atherosclerosis	0.000277	0.000569	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—F2—atherosclerosis	0.000276	0.000569	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—AGT—atherosclerosis	0.000272	0.000559	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—F2—atherosclerosis	0.000271	0.000558	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CCR2—atherosclerosis	0.000268	0.000552	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—EDNRA—atherosclerosis	0.000268	0.000552	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CYBA—atherosclerosis	0.000267	0.000549	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—AGT—atherosclerosis	0.000267	0.000549	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000265	0.000544	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—KNG1—atherosclerosis	0.000264	0.000544	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CCR2—atherosclerosis	0.000263	0.000542	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—EDNRA—atherosclerosis	0.000263	0.000542	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—AGTR1—atherosclerosis	0.000263	0.00054	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CYBA—atherosclerosis	0.000262	0.000539	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PARP1—atherosclerosis	0.000261	0.000538	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PLAT—atherosclerosis	0.000261	0.000538	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—GHRL—atherosclerosis	0.000261	0.000538	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.00026	0.000534	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CCL2—atherosclerosis	0.000258	0.00053	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PARP1—atherosclerosis	0.000257	0.000528	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PLAT—atherosclerosis	0.000257	0.000528	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—GHRL—atherosclerosis	0.000257	0.000528	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PLG—atherosclerosis	0.000256	0.000527	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—F2—atherosclerosis	0.000251	0.000516	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—F2—atherosclerosis	0.000247	0.000507	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—SOCS3—atherosclerosis	0.000242	0.000499	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—PIK3CG—atherosclerosis	0.00024	0.000494	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	0.000236	0.000485	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MMP3—atherosclerosis	0.000234	0.000482	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IGF2—atherosclerosis	0.000233	0.00048	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—KNG1—atherosclerosis	0.000229	0.000472	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—AGTR1—atherosclerosis	0.000228	0.000469	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—APOB—atherosclerosis	0.000226	0.000465	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—KNG1—atherosclerosis	0.000225	0.000463	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—CXCL8—atherosclerosis	0.000224	0.000462	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	0.000224	0.000461	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CCL2—atherosclerosis	0.000224	0.00046	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—EDN1—atherosclerosis	0.000223	0.000458	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PLG—atherosclerosis	0.000222	0.000457	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CCL5—atherosclerosis	0.000221	0.000455	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	0.00022	0.000452	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PLG—atherosclerosis	0.000218	0.000449	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—LPL—atherosclerosis	0.000216	0.000444	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—SOCS3—atherosclerosis	0.000211	0.000433	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PRKCG—atherosclerosis	0.00021	0.000432	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	0.000207	0.000425	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—SPP1—atherosclerosis	0.000205	0.000421	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—CXCL8—atherosclerosis	0.000204	0.000419	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MMP3—atherosclerosis	0.000203	0.000418	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IGF2—atherosclerosis	0.000202	0.000416	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MMP3—atherosclerosis	0.0002	0.000411	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IGF2—atherosclerosis	0.000199	0.000409	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—APOB—atherosclerosis	0.000197	0.000404	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—CXCL8—atherosclerosis	0.000195	0.000401	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—EDN1—atherosclerosis	0.000193	0.000398	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—APOB—atherosclerosis	0.000193	0.000397	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CCL5—atherosclerosis	0.000192	0.000395	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	0.000191	0.000394	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—EDN1—atherosclerosis	0.00019	0.000391	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PDGFB—atherosclerosis	0.000189	0.00039	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CCL5—atherosclerosis	0.000188	0.000388	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—LPL—atherosclerosis	0.000188	0.000386	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—AGT—atherosclerosis	0.000185	0.00038	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—LPL—atherosclerosis	0.000184	0.000379	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PRKCG—atherosclerosis	0.000182	0.000375	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—LEP—atherosclerosis	0.000181	0.000373	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—APOE—atherosclerosis	0.000181	0.000373	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CAV1—atherosclerosis	0.000179	0.000369	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	0.000179	0.000368	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—APOA1—atherosclerosis	0.000179	0.000368	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—SPP1—atherosclerosis	0.000178	0.000366	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—CXCL8—atherosclerosis	0.000177	0.000364	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—SPP1—atherosclerosis	0.000174	0.000359	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	0.000174	0.000357	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—ESR1—atherosclerosis	0.000173	0.000356	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—F2—atherosclerosis	0.000171	0.000351	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PDGFB—atherosclerosis	0.000164	0.000338	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—PIK3CG—atherosclerosis	0.000163	0.000336	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	0.000161	0.000332	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—AGT—atherosclerosis	0.000161	0.00033	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—AGT—atherosclerosis	0.000158	0.000324	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—LEP—atherosclerosis	0.000157	0.000324	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—APOE—atherosclerosis	0.000157	0.000324	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—MAPK3—atherosclerosis	0.000157	0.000322	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CAV1—atherosclerosis	0.000156	0.000321	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—APOA1—atherosclerosis	0.000155	0.00032	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—INS—atherosclerosis	0.000155	0.000318	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—APOE—atherosclerosis	0.000154	0.000318	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—LEP—atherosclerosis	0.000154	0.000318	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CAV1—atherosclerosis	0.000153	0.000315	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—APOA1—atherosclerosis	0.000153	0.000314	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CCL2—atherosclerosis	0.000152	0.000313	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—ESR1—atherosclerosis	0.00015	0.000309	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IGF1—atherosclerosis	0.00015	0.000308	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—F2—atherosclerosis	0.000148	0.000305	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—ESR1—atherosclerosis	0.000147	0.000303	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—F2—atherosclerosis	0.000146	0.0003	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—SERPINE1—atherosclerosis	0.000142	0.000292	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—PIK3CG—atherosclerosis	0.000142	0.000292	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	0.000139	0.000287	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—MAPK3—atherosclerosis	0.000136	0.00028	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NOS3—atherosclerosis	0.000136	0.000279	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—INS—atherosclerosis	0.000134	0.000276	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	0.000133	0.000275	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CCL2—atherosclerosis	0.000132	0.000272	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—INS—atherosclerosis	0.000132	0.000271	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IGF1—atherosclerosis	0.00013	0.000267	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CCL2—atherosclerosis	0.00013	0.000267	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IGF1—atherosclerosis	0.000128	0.000262	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—SERPINE1—atherosclerosis	0.000123	0.000254	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	0.000121	0.000249	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—CXCL8—atherosclerosis	0.00012	0.000248	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NOS3—atherosclerosis	0.000118	0.000242	CbGpPWpGaD
Cyamemazine—HTR2C—GPCR downstream signaling—AKT1—atherosclerosis	0.000116	0.000239	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NOS3—atherosclerosis	0.000116	0.000238	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—IL6—atherosclerosis	0.000114	0.000235	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MMP9—atherosclerosis	0.000109	0.000224	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	0.000108	0.000222	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	0.000106	0.000218	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	0.000106	0.000217	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	0.000105	0.000215	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	0.000103	0.000211	CbGpPWpGaD
Cyamemazine—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	0.000101	0.000208	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—IL6—atherosclerosis	9.94e-05	0.000204	CbGpPWpGaD
Cyamemazine—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	9.91e-05	0.000204	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	9.78e-05	0.000201	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—IL6—atherosclerosis	9.76e-05	0.000201	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—STAT3—atherosclerosis	9.68e-05	0.000199	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MMP9—atherosclerosis	9.45e-05	0.000194	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	9.35e-05	0.000192	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MMP9—atherosclerosis	9.28e-05	0.000191	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	9.25e-05	0.00019	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	9.19e-05	0.000189	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	9.18e-05	0.000189	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	9.17e-05	0.000189	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	9.03e-05	0.000186	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	9e-05	0.000185	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	8.97e-05	0.000185	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	8.49e-05	0.000175	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—STAT3—atherosclerosis	8.41e-05	0.000173	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	8.33e-05	0.000171	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—STAT3—atherosclerosis	8.25e-05	0.00017	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	8.03e-05	0.000165	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	7.88e-05	0.000162	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	7.79e-05	0.00016	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	7.65e-05	0.000157	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—IL6—atherosclerosis	6.76e-05	0.000139	CbGpPWpGaD
Cyamemazine—HTR2C—Signaling Pathways—AKT1—atherosclerosis	6.24e-05	0.000128	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—IL6—atherosclerosis	5.87e-05	0.000121	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—IL6—atherosclerosis	5.76e-05	0.000119	CbGpPWpGaD
Cyamemazine—HTR2A—Signaling Pathways—AKT1—atherosclerosis	5.42e-05	0.000111	CbGpPWpGaD
Cyamemazine—CHRM2—Signaling Pathways—AKT1—atherosclerosis	5.32e-05	0.000109	CbGpPWpGaD
